Leipzig-based biotech startup Primogene has secured €4.1 million in Seed funding, marking its first external capital raise since its 2023 founding. Led by High-Tech Gründerfonds (HTGF), this investment will fuel the expansion of its IP portfolio, strategic partnerships, and production capacities for complex biomolecules like human milk oligosaccharides (HMOs). The funds will also support scaling production, growing the team, and accelerating the industrial launch of their products.
Amount: $4.1M
